Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00052169 · ClinicalTrials.gov registry record · Phase 2
Therapy With Docetaxel and ZD1839 for Patients Who Have Advanced Breast Cancer
A Phase 2 study, sponsored by NSABP Foundation.
- Completed
- Registry status
- Phase 2
- Development phase
- 33
- Enrollment target
NCT00052169 is a Phase 2 study that has completed, run by NSABP Foundation. The registered enrollment target is 33 participants.
The verdict
NCT00052169, a Phase 2 study, has completed, sponsored by NSABP Foundation.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 33 participants
- Enrollment target
Study Summary
The purpose of this study is to learn how breast cancer tumors respond to treatment combining the drugs docetaxel and ZD1839.
Interventions
- DRUG ZD1839 in combination with docetaxel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2003-01 |
| Est. Completion | 2006-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00052169
The ClinicalTrials.gov registry entry for NCT00052169 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NSABP Foundation, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ZD1839 in combination with docetaxel is the first listed.
NCT00052169 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00052169 about?
NCT00052169 is a clinical study titled "Therapy With Docetaxel and ZD1839 for Patients Who Have Advanced Breast Cancer". The purpose of this study is to learn how breast cancer tumors respond to treatment combining the drugs docetaxel and ZD1839.
What is the current status of trial NCT00052169?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 33 participants. The study started on 2003-01. Estimated completion is 2006-09.
What interventions are being tested in trial NCT00052169?
The interventions under investigation include: ZD1839 in combination with docetaxel (DRUG).
Who is sponsoring clinical trial NCT00052169?
This trial is sponsored by NSABP Foundation, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.